Bornaprine

Bornaprine
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral, intravenous, subcutaneous, transdermal
ATC code
Pharmacokinetic data
Elimination half-life30 hours
ExcretionUrine, feces
Identifiers
  • 3-diethylaminopropyl 6-cyclohexylbicyclo[2.2.1]heptane-6-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.205.286 Edit this at Wikidata
Chemical and physical data
FormulaC21H31NO2
Molar mass329.484 g·mol−1
3D model (JSmol)
Density1.056 g/cm3
Boiling point434.3 °C (813.7 °F)
  • O=C(OCCCN(CC)CC)C2(c1ccccc1)CC3CCC2C3
  • InChI=1S/C21H31NO2/c1-3-22(4-2)13-8-14-24-20(23)21(18-9-6-5-7-10-18)16-17-11-12-19(21)15-17/h5-7,9-10,17,19H,3-4,8,11-16H2,1-2H3 checkY
  • Key:BDNMABJZSXTKAQ-UHFFFAOYSA-N checkY
  (verify)

Bornaprine (brand name Sormodrem) is a synthetic anticholinergic medication that is primarily used to treat Parkinson's disease.[1][2] Additionally, bornaprine has been used to treat other disorders, including hyperhidrosis.[3]

  1. ^ Cantello R, Riccio A, Gilli M, Delsedime M, Scarzella L, Aguggia M, Bergamasco B (February 1986). "Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients". Italian Journal of Neurological Sciences. 7 (1): 139–43. doi:10.1007/BF02230432. PMID 3514543.
  2. ^ Jasek W, ed. (2007). Austria-Codex (in German) (62nd ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
  3. ^ Sergi R, Massone A, Moretto S, Oggerino C, Bertolotto F, Losio L, Ottonello M (August 2008). "Hyperhidrosis treatment with bornaprine in the acute phase of spinal cord-injured patients". Spinal Cord. 46 (8): 571–3. doi:10.1038/sc.2008.12. PMID 18332889.